Wikidata

(Q64123258)

English

Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
OPTIMUM (English)
0 references
title
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Belarus
0 references
Bosnia and Herzegovina
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Finland
0 references
France
0 references
Georgia
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Latvia
0 references
Lithuania
0 references
Mexico
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Serbia
0 references
Spain
0 references
Sweden
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
4 June 2015
0 references
end time
23 May 2019
0 references
number of participants
1,133
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64123258&oldid=2234933281"